PONIARD PHARMACEUTICALS, INC. CHANGE OF CONTROL AGREEMENTChange of Control Agreement • February 11th, 2008 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 11th, 2008 Company IndustryThis Change of Control Agreement (this “Agreement”), dated as of February 1, 2008, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 13, the “Company”), and Robert L. De Jager (the “Executive”).
PONIARD PHARMACEUTICALS, INC. KEY EXECUTIVE SEVERANCE AGREEMENTKey Executive Severance Agreement • February 11th, 2008 • Poniard Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledFebruary 11th, 2008 Company IndustryThis Key Executive Severance Agreement (this “Agreement”), dated as of February 1, 2008, is entered into by and between PONIARD PHARMACEUTICALS, INC., a Washington corporation (as supplemented by Section 10, the “Company”), and Robert L. De Jager (the “Executive”).